Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients

(American College of Rheumatology) Rheumatoid arthritis patients in remission may experience more successful tapering of their biologic drugs if they meet a certain set of factors, including younger age, no concomitant steroid use, and low level of serum CRP, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news